UniProt ID | LYPA2_HUMAN | |
---|---|---|
UniProt AC | O95372 | |
Protein Name | Acyl-protein thioesterase 2 | |
Gene Name | LYPLA2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 231 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Hydrolyzes fatty acids from S-acylated cysteine residues in proteins such as trimeric G alpha proteins, GAP43, ZDHHC6 or HRAS. [PubMed: 21152083] | |
Protein Sequence | MCGNTMSVPLLTDAATVSGAERETAAVIFLHGLGDTGHSWADALSTIRLPHVKYICPHAPRIPVTLNMKMVMPSWFDLMGLSPDAPEDEAGIKKAAENIKALIEHEMKNGIPANRIVLGGFSQGGALSLYTALTCPHPLAGIVALSCWLPLHRAFPQAANGSAKDLAILQCHGELDPMVPVRFGALTAEKLRSVVTPARVQFKTYPGVMHSSCPQEMAAVKEFLEKLLPPV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | S-palmitoylation | ------MCGNTMSVP ------CCCCCCCCE | 6.06 | 28826475 | |
18 | Phosphorylation | LTDAATVSGAERETA ECCCCCCCCCHHHHE | 28.12 | 22210691 | |
39 | Phosphorylation | GLGDTGHSWADALST CCCCCCCCHHHHHHH | 25.88 | 21406692 | |
45 | Phosphorylation | HSWADALSTIRLPHV CCHHHHHHHCCCCCC | 24.41 | 21406692 | |
46 | Phosphorylation | SWADALSTIRLPHVK CHHHHHHHCCCCCCE | 15.80 | 21406692 | |
53 | Ubiquitination | TIRLPHVKYICPHAP HCCCCCCEEECCCCC | 26.34 | - | |
53 | Acetylation | TIRLPHVKYICPHAP HCCCCCCEEECCCCC | 26.34 | 25953088 | |
54 | Phosphorylation | IRLPHVKYICPHAPR CCCCCCEEECCCCCC | 13.48 | 28152594 | |
56 | S-nitrosocysteine | LPHVKYICPHAPRIP CCCCEEECCCCCCCC | 1.51 | - | |
56 | S-nitrosylation | LPHVKYICPHAPRIP CCCCEEECCCCCCCC | 1.51 | 19483679 | |
82 | Phosphorylation | WFDLMGLSPDAPEDE HHHHHCCCCCCCCCH | 18.27 | 28348404 | |
93 | Ubiquitination | PEDEAGIKKAAENIK CCCHHHHHHHHHHHH | 35.13 | - | |
100 | Ubiquitination | KKAAENIKALIEHEM HHHHHHHHHHHHHHH | 49.04 | 21890473 | |
107 | Sulfoxidation | KALIEHEMKNGIPAN HHHHHHHHHHCCCCC | 4.39 | 30846556 | |
108 | Acetylation | ALIEHEMKNGIPANR HHHHHHHHHCCCCCC | 49.38 | 25953088 | |
108 | Ubiquitination | ALIEHEMKNGIPANR HHHHHHHHHCCCCCC | 49.38 | 21890473 | |
164 | Ubiquitination | QAANGSAKDLAILQC HHHCCCHHHEEEEEE | 55.78 | - | |
178 | Sulfoxidation | CHGELDPMVPVRFGA ECCCCCCCCCCEECC | 5.48 | 30846556 | |
190 | Acetylation | FGALTAEKLRSVVTP ECCCCHHHHHHCCCC | 46.89 | 25953088 | |
190 | Ubiquitination | FGALTAEKLRSVVTP ECCCCHHHHHHCCCC | 46.89 | 21890473 | |
193 | Phosphorylation | LTAEKLRSVVTPARV CCHHHHHHCCCCCEE | 31.23 | 28857561 | |
203 | Ubiquitination | TPARVQFKTYPGVMH CCCEEEEECCCCCCC | 30.02 | - | |
221 | Ubiquitination | PQEMAAVKEFLEKLL HHHHHHHHHHHHHHC | 37.71 | - | |
226 | Ubiquitination | AVKEFLEKLLPPV-- HHHHHHHHHCCCC-- | 58.43 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LYPA2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LYPA2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LYPA2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DKC1_HUMAN | DKC1 | physical | 16169070 | |
SCMH1_HUMAN | SCMH1 | physical | 16169070 | |
MED31_HUMAN | MED31 | physical | 16169070 | |
A4_HUMAN | APP | physical | 21832049 | |
APT_HUMAN | APRT | physical | 26344197 | |
EI2BA_HUMAN | EIF2B1 | physical | 26344197 | |
LACB2_HUMAN | LACTB2 | physical | 26344197 | |
SPRE_HUMAN | SPR | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...